Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 219,192 | $0.00 Strike: $52.39 | $0.00 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · derivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 219,192 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $56.21 | $5,620.90 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,901 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 94 | $56.21 | $5,283.27 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,001 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,172 | $56.20 | $346,866.40 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,095 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $56.20 | $11,239.80 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,267 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $56.20 | $11,239.50 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,467 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 23,438 | $56.20 | $1,317,098.41 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,667 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,800 | $56.19 | $325,902.00 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,105 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $56.19 | $28,094.50 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,905 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,000 | $56.19 | $449,480.00 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,405 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 18,389 | $56.18 | $1,033,094.02 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,405 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $56.18 | $16,853.70 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,794 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $56.18 | $5,617.75 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,094 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 92,562 | $56.18 | $5,199,670.35 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,194 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 53,071 | $56.17 | $2,980,998.07 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,756 Read SEC document |
| February 22, 2012 Filed Feb 24, 2012 22:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 219,192 | $52.39 | $11,483,468.88 |
DisclosureSEC source: 0001179110-12-003470 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2012 Filed Feb 22, 2012 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,527 | $56.36 | $311,501.72 |
DisclosureSEC source: 0001179110-12-003250 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,635 Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 107,300 | $0.00 Strike: $56.26 | $0.00 |
DisclosureSEC source: 0001179110-12-003250 · edgar.xml · derivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,300 Underlying: Common shares · 107,300 shares Expires 2022-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,767 on 02/17/2013, 35,766 on 02/17/2014, and 35,767 on 02/17/2015. Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 59,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-003250 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,162 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 29, 2011 Filed Dec 21, 2012 19:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 24,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018135 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,432 F1 · balance_after: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 26,528 | $54.70 | $1,451,081.60 |
DisclosureSEC source: 0001179110-11-016497 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,762 Read SEC document |
| November 21, 2011 Filed Dec 12, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-016497 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,290 Read SEC document |
| November 07, 2011 Filed Dec 12, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-016497 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,540 Read SEC document |
| April 06, 2011 Filed Apr 8, 2011 21:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,909 | $49.99 | $345,380.91 |
DisclosureSEC source: 0001179110-11-006263 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,290 Read SEC document |
| February 19, 2011 Filed Feb 23, 2011 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,334 | $46.88 | $250,057.92 |
DisclosureSEC source: 0001179110-11-003272 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,199 Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 55,100 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003272 · edgar.xml · derivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,100 Underlying: Common shares · 55,100 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,367 on 02/18/2012, 18,366 on 02/18/2013, and 18,367 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 39,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003272 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,533 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| July 01, 2010 Filed Jul 2, 2010 21:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011371 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,333 F1 · shares: These shares represent an award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. Read SEC document |
| September 30, 2007 Filed Oct 3, 2007 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,102 | $53.62 | $327,189.24 |
DisclosureSEC source: 0001104659-07-072708 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,108 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.81 | $10,762.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,210 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,278 | $53.80 | $230,156.40 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,410 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,600 | $53.79 | $408,804.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,688 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 18,100 | $53.78 | $973,418.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,288 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,100 | $53.77 | $489,307.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,388 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,100 | $53.76 | $274,176.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,488 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,400 | $53.75 | $666,500.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,588 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,400 | $53.74 | $612,636.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,988 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 18,400 | $53.73 | $988,632.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,388 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 15,100 | $53.72 | $811,172.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,788 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,300 | $53.71 | $445,793.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,888 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,200 | $53.70 | $655,140.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,188 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,700 | $53.69 | $306,033.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,388 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,500 | $53.68 | $241,560.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,088 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,100 | $53.67 | $542,067.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,588 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,100 | $53.66 | $649,286.00 |
DisclosureSEC source: 0001104659-07-070635 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,688 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 69,705 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-070633 · a4.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 69,705 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 179,473 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-070633 · a4.xml · derivative · entry 29 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 Underlying: common shares · 179,473 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 15,800 | $53.65 | $847,670.00 |
DisclosureSEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,788 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,700 | $53.64 | $520,308.00 |
DisclosureSEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,588 Read SEC document |
| September 19, 2007 Filed Sep 22, 2007 00:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,000 | $53.63 | $429,040.00 |
DisclosureSEC source: 0001104659-07-070633 · a4.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,288 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.